Your browser is no longer supported. Please, upgrade your browser.
Settings
STAA STAAR Surgical Company daily Stock Chart
STAA [NASD]
STAAR Surgical Company
Index- P/E371.65 EPS (ttm)0.19 Insider Own0.60% Shs Outstand45.90M Perf Week-12.06%
Market Cap3.21B Forward P/E198.49 EPS next Y0.35 Insider Trans-67.29% Shs Float45.55M Perf Month-6.33%
Income9.00M PEG12.39 EPS next Q0.02 Inst Own90.30% Short Float5.53% Perf Quarter51.92%
Sales156.30M P/S20.56 EPS this Y172.90% Inst Trans-9.02% Short Ratio4.82 Perf Half Y80.08%
Book/sh4.06 P/B17.21 EPS next Y329.27% ROA4.10% Target Price79.60 Perf Year88.74%
Cash/sh2.79 P/C25.05 EPS next 5Y30.00% ROE5.20% 52W Range23.20 - 85.63 Perf YTD98.66%
Dividend- P/FCF1606.66 EPS past 5Y27.40% ROI7.90% 52W High-18.40% Beta1.27
Dividend %- Quick Ratio5.30 Sales past 5Y14.90% Gross Margin72.20% 52W Low201.16% ATR4.68
Employees550 Current Ratio5.80 Sales Q/Q20.50% Oper. Margin3.30% RSI (14)41.42 Volatility6.38% 6.14%
OptionableYes Debt/Eq0.01 EPS Q/Q58.50% Profit Margin5.70% Rel Volume1.13 Prev Close73.47
ShortableYes LT Debt/Eq0.00 EarningsNov 04 AMC Payout0.00% Avg Volume522.62K Price69.87
Recom1.70 SMA20-9.92% SMA503.97% SMA20042.30% Volume590,295 Change-4.90%
Oct-26-20Downgrade Sidoti Buy → Neutral
Aug-31-20Upgrade Sidoti Neutral → Buy $58
Aug-06-20Reiterated The Benchmark Company Buy $50 → $66
Jul-06-20Downgrade Sidoti Buy → Neutral $58
Jun-24-20Downgrade BTIG Research Buy → Neutral
Jun-15-20Initiated Jefferies Buy $55
Dec-04-19Initiated BTIG Research Buy
Sep-24-18Reiterated The Benchmark Company Buy $45 → $54
Aug-06-18Resumed The Benchmark Company Buy $45
Nov-20-17Reiterated The Benchmark Company Buy $21
Aug-14-17Reiterated The Benchmark Company Buy $12 → $13
Mar-03-17Reiterated The Benchmark Company Buy $10 → $12
May-18-16Upgrade The Benchmark Company Hold → Buy $6
Sep-10-13Resumed The Benchmark Company Buy $15
Feb-28-13Reiterated The Benchmark Company Buy $10 → $6.50
Nov-01-12Downgrade Canaccord Genuity Buy → Hold $8.25 → $7
Mar-02-12Initiated Northland Securities Outperform $14
Oct-25-11Reiterated The Benchmark Company Buy $10 → $12.50
Oct-12-10Initiated Morgan Joseph Buy $6.40
May-11-10Initiated Benchmark Buy $7
Nov-09-20 02:57PM  
Nov-04-20 10:02PM  
05:35PM  
04:03PM  
04:01PM  
02:30PM  
Oct-28-20 12:32PM  
Oct-21-20 07:00AM  
Oct-19-20 03:09PM  
01:43PM  
12:35PM  
12:30PM  
12:11PM  
11:50AM  
11:30AM  
10:00AM  
09:53AM  
08:24AM  
08:02AM  
06:35AM  
Oct-18-20 10:45PM  
10:33AM  
08:00AM  
Oct-17-20 01:56PM  
11:10AM  
Oct-16-20 09:03PM  
04:55PM  
03:37PM  
02:44PM  
02:40PM  
02:01PM  
01:15PM  
11:15AM  
11:00AM  
10:45AM  
Oct-15-20 04:07PM  
02:41PM  
02:22PM  
11:30AM  
11:00AM  
10:51AM  
Oct-14-20 02:25PM  
02:10PM  
01:07PM  
11:30AM  
11:00AM  
11:00AM  
10:27AM  
Oct-13-20 08:28PM  
08:15PM  
06:00PM  
01:30PM  
12:00PM  
11:45AM  
11:15AM  
11:00AM  
10:24AM  
Oct-12-20 04:55PM  
04:30PM  
03:38PM  
02:50PM  
12:00PM  
12:00PM  
11:15AM  
11:00AM  
09:31AM  
08:00AM  
08:00AM  
06:20AM  
Oct-11-20 03:35PM  
10:35AM  
Oct-10-20 11:50PM  
02:43PM  
Oct-09-20 09:25PM  
07:53PM  
06:40PM  
05:50PM  
04:40PM  
01:30PM  
01:00PM  
11:29AM  
10:01AM  
06:21AM  
Oct-08-20 10:59PM  
09:17PM  
08:00PM  
06:36PM  
04:25PM  
12:30PM  
10:01AM  
10:00AM  
08:00AM  
06:57AM  
Oct-07-20 09:16PM  
06:51PM  
06:32PM  
02:00PM  
01:45PM  
01:45PM  
12:30PM  
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells its products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in China, Korea, India, and internationally. STAAR Surgical Company was founded in 1982 and is based in Lake Forest, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaNov 23Option Exercise15.541,90029,526113,155Nov 23 04:51 PM
Francese James ESr. VP, Comm. Ops., NA, APACNov 23Option Exercise9.1418,959173,28870,342Nov 25 04:08 PM
Francese James ESr. VP, Comm. Ops., NA, APACNov 23Sale80.1318,9591,519,18551,383Nov 25 04:08 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaNov 23Sale83.094,774396,682108,381Nov 23 04:51 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaNov 20Sale83.022,688223,158111,255Nov 23 04:51 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaNov 19Option Exercise15.5412,156188,904140,106Nov 23 04:51 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaNov 19Sale82.0314,0071,148,994113,943Nov 23 04:51 PM
Barnes Scott DChief Medical OfficerNov 16Option Exercise34.4922,593779,33942,983Nov 17 04:52 PM
Holliday KeithChief Technology OfficerNov 09Option Exercise8.2138,714317,82958,046Nov 12 04:50 PM
Moore John CDirectorNov 09Option Exercise14.0916,206228,32718,323Nov 12 04:48 PM
Hayashida Jon K.VP, Global Clinical, MedicalNov 09Option Exercise23.1120,000462,23030,794Nov 12 04:51 PM
Holliday KeithChief Technology OfficerNov 09Sale81.5623,7141,934,11434,332Nov 12 04:50 PM
Hayashida Jon K.VP, Global Clinical, MedicalNov 09Sale81.3420,0001,626,80010,794Nov 12 04:51 PM
Holliday KeithChief Technology OfficerSep 15Option Exercise27.0436,326982,42455,658Sep 16 06:01 PM
Holliday KeithChief Technology OfficerSep 15Sale53.3336,3261,937,26619,332Sep 16 06:01 PM
Holliday KeithChief Technology OfficerSep 14Option Exercise10.2426,574272,20855,021Sep 16 06:01 PM
Holliday KeithChief Technology OfficerSep 14Sale53.3235,6891,902,89319,332Sep 16 06:01 PM
Moore John CDirectorSep 09Sale52.04137,3317,146,70521,387Sep 11 04:07 PM
Hayashida Jon K.VP, Global Clinical, MedicalAug 10Option Exercise10.1841,602423,69752,396Aug 12 06:30 PM
Hayashida Jon K.VP, Global Clinical, MedicalAug 10Sale51.2241,6022,130,85410,794Aug 12 06:30 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaJun 15Option Exercise8.1139,215318,165167,165Jun 17 05:03 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaJun 15Sale44.0739,2151,728,205127,950Jun 17 05:03 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaJun 10Option Exercise11.007858,635128,735Jun 12 04:01 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaJun 10Sale44.0078534,540127,950Jun 12 04:01 PM
Gesten Samuel JChief Legal OfficerMay 21Sale40.00192,5227,700,88041,185May 26 04:16 PM
Holliday KeithChief Technology OfficerMay 15Option Exercise7.2025,000180,00053,447May 15 06:10 PM
Holliday KeithChief Technology OfficerMay 15Sale37.6925,000942,25028,447May 15 06:10 PM
Francese James ESr. VP, Comm. Ops., NA, APACMay 13Option Exercise5.346,66735,60251,133May 13 06:49 PM
Hayashida Jon K.VP, Global Clinical, MedicalMay 11Option Exercise8.4846,563394,87957,357May 13 06:50 PM
Hansen Graydon C.Sr. VP, Global OperationsMay 11Option Exercise13.6620,283277,01929,972May 13 06:48 PM
Francese James ESr. VP, Comm. Ops., NA, APACMay 11Option Exercise12.0718,856227,50263,322May 13 06:49 PM
Hayashida Jon K.VP, Global Clinical, MedicalMay 11Sale39.1146,5631,821,07910,794May 13 06:50 PM
Francese James ESr. VP, Comm. Ops., NA, APACMay 11Sale39.0618,856736,51544,466May 13 06:49 PM
Hansen Graydon C.Sr. VP, Global OperationsMay 11Sale39.0218,189709,70816,022May 13 06:48 PM
Hayashida Jon K.VP, Global Clinical, MedicalMar 23Sale26.832,81375,47310,794Mar 24 04:18 PM
Hansen Graydon C.Sr. VP, Global OperationsMar 23Sale27.422,81377,13219,459Mar 24 04:16 PM
Gesten Samuel JChief Legal OfficerMar 23Sale27.422,74275,18641,185Mar 24 04:14 PM
Francese James ESr. VP, Comm. Ops., NA, APACMar 23Sale26.772,25060,23344,466Mar 24 04:13 PM
ANDREWS DEBORAH JChief Financial OfficerMar 23Sale27.4283422,86831,267Mar 24 04:09 PM
Moore John CDirectorMar 18Option Exercise5.8110,00058,10066,422Mar 19 04:15 PM
ANDREWS DEBORAH JChief Financial OfficerJan 21Option Exercise11.11106,6041,184,228138,705Jan 23 04:06 PM
ANDREWS DEBORAH JChief Financial OfficerJan 21Sale42.20106,6044,498,68932,101Jan 23 04:06 PM
Hayashida Jon K.VP, Global Clinical, MedicalDec 05Option Exercise8.6432,335279,37453,658Dec 06 04:35 PM
Hayashida Jon K.VP, Global Clinical, MedicalDec 05Sale37.2047,4081,763,6196,250Dec 06 04:35 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaDec 04Option Exercise5.6045,000251,800149,200Dec 06 04:34 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaDec 04Sale38.1545,0001,716,750124,200Dec 06 04:34 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.